Cargando…

GA101 (a Novel Anti-CD20 Monoclonal Antibody)-Induced Lichenoid Eruption

INTRODUCTION: Obinutuzumab (GA101) is a novel anti-CD20 monoclonal antibody that has been shown to be effective for the treatment of non-Hodgkin’s lymphoma, and is currently being evaluated in phase 3 clinical trials. The side-effect profile of the drug is not yet well established. CASE REPORT: The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bakkour, Waseem, Coulson, Ian H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare Communications 2012
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510425/ https://www.ncbi.nlm.nih.gov/pubmed/23205326 http://dx.doi.org/10.1007/s13555-012-0003-9

Ejemplares similares

A Review of Obinutuzumab (GA101), a Novel Type II Anti-CD20 Monoclonal Antibody, for the Treatment of Patients with B-Cell Malignancies
por: Tobinai, Kensei, et al.
Publicado: (2016)

Tenofovir induced lichenoid drug eruption
por: Gupta, Mrinal, et al.
Publicado: (2015)

Lichenoid drug eruption associated with Bendamustine
por: Kusano, Y, et al.
Publicado: (2016)

Lichenoid drug eruption induced by erenumab
por: Musicante, Meryl, et al.
Publicado: (2022)

Isoniazid-induced lichenoid eruption reaction
por: Kedar, Aishwarya Kishor, et al.
Publicado: (2023)

Lichenoid Drug Eruption Induced by Teriflunomide
por: Agharbi, Fatima-Zahra, et al.
Publicado: (2023)

Ofatumumab: a novel monoclonal anti-CD20 antibody
por: Lin, Thomas S
Publicado: (2010)

Lichenoid drug eruption due to eprosartan/hydrochlorothiacide
por: Ruiz-Villaverde, Ricardo, et al.
Publicado: (2011)

Lichenoid drug eruption due to imatinib mesylate
por: Bhatia, Anuradha, et al.
Publicado: (2015)

Inverse lichenoid drug eruption associated with nivolumab
por: Guggina, Lauren M., et al.
Publicado: (2016)

Blaschkoid Lichenoid Drug Eruption Due to Tenofovir
por: Virath, Rekha, et al.
Publicado: (2020)

Denosumab-induced alopecia areata with lichenoid eruption
por: Dourra, Mohsen, et al.
Publicado: (2021)

Dermoscopy of “Lichenoid Pseudovesicular Papular Eruption on Nose”
por: Bains, Anupama, et al.
Publicado: (2021)

A case of lichenoid drug eruption associated with relugolix
por: Han, Joseph, et al.
Publicado: (2023)

Immune checkpoint inhibitor lichenoid eruption due to pembrolizumab
por: McCormick, Benjamin Joseph, et al.
Publicado: (2023)

Novel CD20 monoclonal antibodies for lymphoma therapy
por: Cang, Shundong, et al.
Publicado: (2012)

Anti-CD20 monoclonal antibodies: reviewing a revolution
por: Casan, J. M. L., et al.
Publicado: (2018)

Vasculitis with lichenoid eruptions in Hepatitis B infection – case report
por: Sundaram, Murugan, et al.
Publicado: (2014)

Generalized Lichenoid Drug Eruption Associated with Imatinib Mesylate Therapy
por: Ghosh, Sudip Kumar
Publicado: (2013)

Giant annular lichenoid drug eruption caused by efavirenz therapy
por: Baumrin, Emily, et al.
Publicado: (2018)

Fenofibrate-Induced Lichenoid Drug Eruption: A Rare Culprit
por: Mohammed, Fayeza, et al.
Publicado: (2017)

A rare case report of apixaban-induced lichenoid eruption
por: Patil, Tanvi, et al.
Publicado: (2020)

Clonazepam-induced lichenoid drug eruption: a case report
por: Yang, Hee Won, et al.
Publicado: (2021)

De novo case of lichenoid eruption following dupilumab treatment
por: Kim, Tae-Eun, et al.
Publicado: (2021)

Obinutuzumab: A Novel Anti-CD20 Monoclonal Antibody for Chronic Lymphocytic Leukemia
por: Evans, Sarah S., et al.
Publicado: (2015)

A novel glycosylated anti-CD20 monoclonal antibody from transgenic cattle
por: Zhang, Ran, et al.
Publicado: (2018)

Monoclonal antibodies targeting CD20
por: Chang, Chien-Hsing, et al.
Publicado: (2013)

Enhanced anti-tumor activity of the glycoengineered type II CD20 antibody obinutuzumab (GA101) in combination with chemotherapy in xenograft models of human lymphoma
por: Herting, Frank, et al.
Publicado: (2014)

Lichenoid Drug Eruption after Low-Dose Imatinib Mesylate Treatment
por: Lee, Jae-Hyung, et al.
Publicado: (2013)

Prominent Alopetic Lesions of Lichenoid Drug Eruption Treated with Topical Tacrolimus
por: Cho, Hong Ki, et al.
Publicado: (2014)

Annular lichenoid eruption following treatment with casirivimab/imdevimab for COVID-19
por: Markovitz, Netana H., et al.
Publicado: (2022)

Lichenoid drug eruption induced by pravastatin; it is possible to prescribe other statins?()
por: Navarro-Triviño, Francisco J., et al.
Publicado: (2023)

Lichenoid Pseudovesicular Papular Eruption on Nose: A Rare Distinct Entity
por: Mohanty, Prasenjeet, et al.
Publicado: (2022)

Development of Novel Anti-Cd20 Monoclonal Antibodies and Modulation in Cd20 Levels on Cell Surface: Looking to Improve Immunotherapy Response
por: Singh, Vijay, et al.
Publicado: (2015)

Establishment of C(20)Mab-11, a novel anti-CD20 monoclonal antibody, for the detection of B cells
por: Furusawa, Yoshikazu, et al.
Publicado: (2020)

A case of durvalumab-induced lichenoid eruption evolving to bullous eruption after phototherapy: A case report
por: Manko, Svitlana, et al.
Publicado: (2021)

Response to: Monoclonal antibodies targeting CD20
por: Klein, Christian, et al.
Publicado: (2013)

Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies
por: Dillman, R. O.
Publicado: (2006)

Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment
por: Du, Fanny Huynh, et al.
Publicado: (2017)

Review of an Anti-CD20 Monoclonal Antibody for the Treatment of Autoimmune Diseases of the Skin
por: Ly, Sophia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kaq0pae1b79k1n2t1varj8lc6s